Rein Verbeke

Dr. Rein Verbeke is a senior postdoc in the Ghent Research Group on Nanomedicines (Ghent University, https://www.drugdelivery.be ). His PhD focused on the design of mRNA-LNPs and the adjuvancy of mRNA vaccines. Rein continued his research on the validation of a glycolipid-adjuvanted mRNA vaccine (Galsomes) for cancer and intracellular bacterial infections. In 2022, he visited the group of Prof. Pieter Cullis, University of British Columbia, where he investigated the contribution of LNPs to the immunogenicity and reactogenicity of mRNA vaccines. Rein is also director of the Ghent Nanomedicine Center providing solutions for the formulation and in-depth characterization of bio-therapeutics in nanoparticles (https://www.nanomedicinecentre.com).